Evidence map›Paper›PMID 32793303›Full record

ArticleBiotechnology for biofuels2020

A new synergistic relationship between xylan-active LPMO and xylobiohydrolase to tackle recalcitrant xylan.

Anastasia Zerva, Christina Pentari, Sacha Grisel, Jean-Guy Berrin, Evangelos Topakas

Abstract read
In one paragraph

Article in Biotechnology for biofuels, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Enzymatic production of prebiotic xylooligosaccharides.World journal of microbiology & biotechnology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anastasia ZervaIndustrial Biotechnology and Biocatalysis Group, School of Chemical Engineering, National Technical University of Athens, 9 Iroon Polytechniou Str., Zografou Campus, 15780 Athens, Greece.
Christina PentariIndustrial Biotechnology and Biocatalysis Group, School of Chemical Engineering, National Technical University of Athens, 9 Iroon Polytechniou Str., Zografou Campus, 15780 Athens, Greece.
Sacha GriselINRAE, Aix Marseille University, Biodiversité Et Biotechnologie Fongiques (BBF), UMR1163, 13009 Marseille, France.
Jean-Guy BerrinINRAE, Aix Marseille University, Biodiversité Et Biotechnologie Fongiques (BBF), UMR1163, 13009 Marseille, France.
Evangelos TopakasIndustrial Biotechnology and Biocatalysis Group, School of Chemical Engineering, National Technical University of Athens, 9 Iroon Polytechniou Str., Zografou Campus, 15780 Athens, Greece.ORCID 0000-0003-0078-5904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemicellulose accounts for a significant part of plant biomass, and still poses a barrier to the efficient saccharification of lignocellulose. The recalcitrant part of hemicellulose is a serious impediment to the action of cellulases, despite the use of xylanases in the cellulolytic cocktail mixtures. However, the complexity and variety of hemicelluloses in different plant materials require the use of highly specific enzymes for a complete breakdown. Over the last few years, new fungal enzymes with novel activities on hemicelluloses have emerged. In the present study, we explored the synergistic relationships of the xylan-active AA14 lytic polysaccharide monooxygenase (LPMO),

results

conclusionsThe results of the present study revealed a new synergistic relationship not only among two recently discovered xylan-active enzymes, the LPMO

Indexed as

AA14GH30LignocelluloseSynergismXylanaseXylobiohydrolase

Identifiers

PMID32793303
PMCPMC7419196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.